By Professor Andrew Lloyd

Journal articles

Mina MM; Clark PJ; Beasley HM; Herawati L; Butler TG; Lloyd AR, 2014, 'Enhancing hepatitis C treatment in the custodial setting: A national roadmap', Medical Journal of Australia, 200, pp. 15 - 16, http://dx.doi.org/10.5694/mja13.10654

Leung P; Bull R; Lloyd A; Luciani F, 2014, 'Erratum: "A bioinformatics pipeline for the analyses of viral escape dynamics and host immune responses during an infection" (BioMed Research International)', BioMed Research International, 2014, http://dx.doi.org/10.1155/2014/680249

Hovey E; De Souza P; Marx G; Parente P; Rapke T; Hill A; Bonaventura A; Michele A; Craft P; Abdi E; Lloyd A, 2014, 'Phase III, randomized, double-blind, placebo-controlled study of modafinil for fatigue in patients treated with docetaxel-based chemotherapy', Supportive Care in Cancer, 22, pp. 1233 - 1242, http://dx.doi.org/10.1007/s00520-013-2076-0

Nguyen N; de Esch C; Cameron B; Kumar RK; Zekry A; Lloyd AR, 2014, 'Positioning of leukocyte subsets in the portal and lobular compartments of hepatitis C virus-infected liver correlates with local chemokine expression', Journal of Gastroenterology and Hepatology (Australia), 29, pp. 860 - 869, http://dx.doi.org/10.1111/jgh.12462

Nguyen N; Hampartzoumian T; Cameron B; Palmer C; O'Toole S; Post J; Zekry A; Lloyd A, 2014, 'Regulation of T cell recruitment and inflammation in the human immunodeficiency virus/hepatitis C virus coinfected liver', Journal of Gastroenterology and Hepatology (Australia), 29, pp. 1535 - 1543, http://dx.doi.org/10.1111/jgh.12543

Grebely J; Page K; Sacks-Davis R; van der Loeff MS; Rice TM; Bruneau J; Morris MD; Hajarizadeh B; Amin J; Cox AL; Kim AY; Mcgovern BH; Schinkel J; George J; Shoukry NH; Lauer GM; Maher L; Lloyd AR; Hellard M; Dore GJ; Prins M, 2014, 'The effects of female sex, viral genotype, and IL28B genotype on spontaneous clearance of acute hepatitis C virus infection', Hepatology, 59, pp. 109 - 120, http://dx.doi.org/10.1002/hep.26639

Vollmer-Conna U; Piraino B; Lloyd A, 2014, '41. Immunogenetic and phenotypic explorations of the acute sickness response to common infections', Brain, Behavior, and Immunity, 40, pp. e12 - e13, http://dx.doi.org/10.1016/j.bbi.2014.06.061

Vollmer-Conna U; Cvejic E; Gunawardane U; Hadzi-Pavlovic D; Cameron B; Lloyd A, 2014, '42. Post-infective fatigue syndrome: Immunological and autonomic findings', Brain, Behavior, and Immunity, 40, pp. e13 - e13, http://dx.doi.org/10.1016/j.bbi.2014.06.062

Cvejic E; Lloyd A; Vollmer-Conna U, 2014, '43. Neurocognitive disturbances associated with acute infections: An investigation of inflammatory and genetic correlates', Brain, Behavior, and Immunity, 40, pp. e13 - e13, http://dx.doi.org/10.1016/j.bbi.2014.06.063

Hartfield M; Bull R; White PA; Lloyd A; Luciani F; Alizon S; Maher L, 2014, 'Evidence that hepatitis C virus genome partly controls infection outcome', Evolutionary Applications, 7, pp. 533 - 547, http://dx.doi.org/10.1111/eva.12151

Sugden PB; Cameron B; Luciani F; Lloyd AR; Maher L, 2014, 'Exploration of genetically determined resistance against hepatitis C infection in high-risk injecting drug users', Journal of Viral Hepatitis, 21, pp. e65 - e73, http://dx.doi.org/10.1111/jvh.12232

Sugden PB; Cameron B; Mina M; Lloyd AR; Luciani F; Maher L; Dolan K, 2014, 'Protection against hepatitis C infection via NK cells in highly-exposed uninfected injecting drug users', Journal of Hepatology, 61, pp. 738 - 745, http://dx.doi.org/10.1016/j.jhep.2014.05.013

Ahmadzai H; Cameron B; Chui J; Lloyd A; Wakefield D; Thomas PS, 2013, 'Measurement of neopterin, TGF-β1 and ACE in the exhaled breath condensate of patients with sarcoidosis', Journal of Breath Research, 7, http://dx.doi.org/10.1088/1752-7155/7/4/046003

Gunaratne P; Lloyd AR; Vollmer-Conna U, 2013, 'Mood disturbance after infection', Australian and New Zealand Journal of Psychiatry, 47, pp. 1152 - 1164, http://dx.doi.org/10.1177/0004867413503718

Feld JJ; Grebely J; Matthews GV; Applegate T; Hellard M; Sherker A; Cherepanov V; Petoumenos K; Yeung B; Kaldor JM; Lloyd AR; Dore GJ, 2013, 'Plasma interferon-gamma-inducible protein-10 levels are associated with early, but not sustained virological response during treatment of acute or early chronic HCV infection', PLoS ONE, 8, pp. e80003, http://dx.doi.org/10.1371/journal.pone.0080003

Post JJ; Lloyd AR; Monkley D, 2013, 'Treatment outcomes for indigenous and non-indigenous inmates with hepatitis C in New South Wales prisons', Medical Journal of Australia, 199, pp. 464, http://dx.doi.org/10.5694/mja13.10925

Grebely J; Matthews GV; Lloyd AR; Dore GJ, 2013, 'Elimination of hepatitis C virus infection among people who inject drugs through treatment as prevention: Feasibility and future requirements', Clinical Infectious Diseases, 57, pp. 1014 - 1020, http://dx.doi.org/10.1093/cid/cit377

Lloyd AR, 2013, 'Fatigue after infection: aetiology and pathophysiology', MICROBIOLOGY AUSTRALIA, 34, pp. 142 - 144, http://dx.doi.org/10.1071/MA13047

Post JJ; Arain A; Lloyd AR, 2013, 'Enhancing assessment and treatment of hepatitis c in the custodial setting', Clinical Infectious Diseases, 57, http://dx.doi.org/10.1093/cid/cit265

Lloyd AR, 2013, 'Apology', Journal of Internal Medicine, 273, pp. 628 - 628, http://dx.doi.org/10.1111/joim.12074

Grebely J; Feld JJ; Applegate T; Matthews GV; Hellard M; Sherker A; Petoumenos K; Zang G; Shaw I; Yeung B; George J; Teutsch S; Kaldor JM; Cherepanov V; Bruneau J; Shoukry NH; Lloyd AR; Dore GJ, 2013, 'Plasma interferon-gamma-inducible protein-10 (IP-10) levels during acute hepatitis C virus infection', Hepatology, 57, pp. 2124 - 2134, http://dx.doi.org/10.1002/hep.26263

Lloyd AR; Clegg J; Lange J; Stevenson A; Post JJ; Lloyd D; Rudge G; Boonwaat L; Forrest G; Douglas J; Monkley D, 2013, 'Safety and effectiveness of a nurse-led outreach program for assessment and treatment of chronic hepatitis c in the custodial setting', Clinical Infectious Diseases, 56, pp. 1078 - 1084, http://dx.doi.org/10.1093/cid/cis1202

Flynn JK; Dore GJ; Hellard M; Yeung B; Rawlinson WD; White PA; Kaldor JM; Lloyd AR; Ffrench RA; Dolan K, 2013, 'Maintenance of Th1 hepatitis C virus (HCV)-specific responses in individuals with acute HCV who achieve sustained virological clearance after treatment', Journal of Gastroenterology and Hepatology (Australia), 28, pp. 1770 - 1781, http://dx.doi.org/10.1111/jgh.12265

Vollmer-Conna U; Piraino B; Lloyd AR, 2013, '26. Polymorphisms in both immune and behavioural genes affect mood as part of the acute sickness response to infection', Brain, Behavior, and Immunity, 32, pp. e8 - e8, http://dx.doi.org/10.1016/j.bbi.2013.07.038

Vollmer-Conna U; Gunawardane U; Patel V; Cvejic E; Lloyd AR, 2013, '39. Vagus nerve activity, a good night’s sleep, and recovery from acute infection', Brain, Behavior, and Immunity, 32, pp. e11 - e12, http://dx.doi.org/10.1016/j.bbi.2013.07.051

Cameron B; Galbraith S; Li H; Lloyd A; HITS investigators , 2013, 'Correlates and characteristics of hepatitis C virus-specific T-cell immunity in exposed uninfected high-risk prison inmates', Journal of Viral Hepatitis, 20, pp. e96 - e106, http://dx.doi.org/10.1111/jvh.12016

Post J; Arain A; Lloyd AR; Grebely J; Dore G, 2013, 'Enhancing Assessment and Treatment Hepatitis C in the Custodial Setting', Clinical Infectious Diseases, 57, pp. S70 - S74, http://dx.doi.org/10.1093/cid/cit264

Chang CC; Crane M; Zhou J; Mina M; Post JJ; Cameron BA; Lloyd AR; Jaworowski A; French MA; Lewin SR, 2013, 'HIV and co-infections', Immunological Reviews, 254, pp. 114 - 142, http://dx.doi.org/10.1111/imr.12063

Sugden PB; Pham TN; Ratnarajah S; Cameron B; Bull R; White PA; Michalak TI; Lloyd AR, 2013, 'Rare occurrence of occult hepatitis C virus in apparently uninfected injecting drug users: a two-centre, masked, case-control study', J Viral Hepat, 20, pp. 725 - 728, http://dx.doi.org/10.1111/jvh.12098

Goldstein D; Bennett BK; Webber K; Lloyd AR, 2012, 'Reply to A. Giacalone et al', Journal of Clinical Oncology, 30, pp. 4175 - 4176, http://dx.doi.org/10.1200/JCO.2012.45.6269

Mccredie L; Luciani F; Teutsch S; Amin J; Topp L; Dolan K; Lloyd A, 2012, 'BLOODY PRISONS: INCIDENCE OF RISK BEHAVIOURS AND HEPATITIS C VIRUS TRANSMISSION IN AN AUSTRALIAN PRISONER COHORT', DRUG AND ALCOHOL REVIEW, 31, pp. 57 - 57, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000311236700175&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Hovey E; de Souza P; Marx G; Parente P; Rapke T; Hill A; Bonaventura A; Michele A; Kraft P; Lloyd A, 2012, 'PHASE III, RANDOMISED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY OF MODAFINIL FOR FATIGUE IN PATIENTS TREATED WITH DOCETAXEL-BASED CHEMOTHERAPY', ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 8, pp. 44 - 44, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000306960100015&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Hovey EJ; De Souza PL; Marx GM; Rapke T; Parente P; Hill A; Bonaventura A; Michele A; Craft PS; Abdi EA; Lloyd AR, 2012, 'Modafinil for fatigue associated with docetaxel-based chemotherapy: A randomized controlled trial.', Journal of Clinical Oncology, 30, pp. e15152 - e15152, http://dx.doi.org/10.1200/jco.2012.30.15_suppl.e15152

Bennett BK; Lloyd AR; Webber K; Friedlander M; Goldstein D, 2012, 'Predictors of resilience in women treated for breast cancer: A prospective study.', Journal of Clinical Oncology, 30, pp. 9044 - 9044, http://dx.doi.org/10.1200/jco.2012.30.15_suppl.9044

Sugden PB; Cameron B; Bull RA; White PA; Lloyd AR, 2012, 'Occult infection with hepatitis C virus: friend or foe?', , http://dx.doi.org/10.1038/icb.2012.20

Hovey EJ; De Souza PL; Marx GM; Parente P; Rapke T; Hill A; Bonaventura A; Michele A; Craft PS; Abdi EA; Lloyd AR, 2012, 'Modafinil for fatigue associated with docetaxel-based chemotherapy: A randomized controlled trial', JOURNAL OF CLINICAL ONCOLOGY, 30, http://dx.doi.org/10.1200/jco.2012.30.5_suppl.211

Hovey EJ; De Souza PL; Marx GM; Parente P; Rapke T; Hill A; Bonaventura A; Michele A; Craft PS; Abdi EA; Lloyd AR, 2012, 'Modafinil for fatigue associated with docetaxel-based chemotherapy: A randomized controlled trial.', J Clin Oncol, 30, pp. 211, http://www.ncbi.nlm.nih.gov/pubmed/27967925

Grebely J; Prins M; Hellard M; Cox AL; Osburn WO; Lauer G; Page K; Lloyd AR; Dore GJ; Maher L, 2012, 'Hepatitis C virus clearance, reinfection, and persistence, with insights from studies of injecting drug users: towards a vaccine', Lancet Infectious Diseases, 12, pp. 408 - 414, http://dx.doi.org/10.1016/s1473-3099(12)70010-5

Grebely J; Hellard M; Applegate TL; Petoumenos K; Yeung B; Feld J; Rawlinson WD; Lloyd AR; George J; Kaldor JM; Dore GJ; Matthews G; Dolan K, 2012, 'Virological responses during treatment for recent hepatitis C virus: Potential benefit for ribavirin use in HCV/HIV co-infection', AIDS, 26, pp. 1653 - 1661, http://dx.doi.org/10.1097/qad.0b013e3283553719

Nguyen N; Luciani F; Cameron B; Keoshkerian E; Zekry A; Lloyd A, 2012, '801 T CELLS CO-EXPRESSING CCR2, CCR5, CXCR3, AND CXCR6 ARE PREFERENTIALLY ENRICHED IN THE HCV-INFECTED LIVER', Journal of Hepatology, 56, pp. S313 - S313, http://dx.doi.org/10.1016/s0168-8278(12)60813-7

Van Der Meer J; Lloyd AR, 2012, 'A controversial consensus – comment on article by Brodericket al', Internal Medicine Journal, 271, pp. 29 - 31, http://dx.doi.org/10.1111/j.1365-2796.2011.02468.x

Keoshkerian E; Helbig K; Beard M; Zaunders J; Seddiki N; Kelleher AD; Hampartzoumian T; Zekry A; Lloyd AR, 2012, 'A novel assay for detection of hepatitis C virus-specific effector CD4(+) T cells via co-expression of CD25 and CD134', Journal of Immunological Methods, 375, pp. 148 - 158, http://dx.doi.org/10.1016/j.jim.2011.10.004

Goldstein D; Bennett BK; Webber K; Boyle F; De Souza P; Wilcken NRC; Scott E; Toppler R; Murie P; O''Malley L; Mccourt J; Friedlander M; Hickie IB; Lloyd AR, 2012, 'Cancer-related fatigue in women with breast cancer: outcomes of a 5 year prospective cohort study.', Journal of Clinical Oncology, 30, pp. 1805 - 1812, http://dx.doi.org/10.1200/JCO.2011.34.6148

Scott GM; Chow SS; Craig ME; Pang CN; Hall B; Wilkins MR; Jones C; Lloyd AR; Rawlinson WD; hall B, 2012, 'Cytomegalovirus infection during pregnancy with maternofetal transmission induces a proinflammatory cytokine bias in placenta and amniotic fluid', Journal of Infectious Diseases, 205, pp. 1305 - 1310, http://dx.doi.org/10.1093/infdis/jis186

Grebely J; Matthews GV; Petoumenos K; Yeung B; Day C; Lloyd AR; Beek IV; Kaldor JM; Hellard M; Dore GJ; Haber PS; Alavi M; Van Beek I; Amin J; Dolan K; Rawlinson W; Flynn J; Marks P; Acraman B; Bloch M; Li H; Madden A; George J, 2012, 'Effect of pegylated interferon-a-2a treatment on mental health during recent hepatitis C virus infection', Journal of Gastroenterology and Hepatology, 27, pp. 957 - 965, http://dx.doi.org/10.1111/j.1440-1746.2011.07035.x

Piraino BF; Vollmer-Conna US; Lloyd AR, 2012, 'Genetic associations of fatigue and other symptom domains of the acute sickness response to infection', Brain Behavior and Immunity, 26, pp. 552 - 558, http://dx.doi.org/10.1016/j.bbi.2011.12.009

Grebely J; Pham ST; Matthews G; Petoumenos K; Bull RA; Yeung B; Rawlinson WD; Kaldor JM; Lloyd AR; Hellard M; Dore GJ; White PA; Bull ; Dolan K, 2012, 'Hepatitis C virus reinfection and superinfection among treated and untreated participants with recent infection', Hepatology, 55, pp. 1058 - 1069, http://dx.doi.org/10.1002/hep.24754

Flynn J; Dore GJ; Matthews G; Hellard M; Yeung B; Rawlinson W; White PA; Kaldor JM; Lloyd AR; Ffrench RA; Dolan K, 2012, 'Impaired hepatitis C virus (HCV)-specific interferon-responses in individuals with HIV who acquire HCV infection: Correlation with CD4 + T-cell counts', Journal of Infectious Diseases, 206, pp. 1568 - 1576, http://dx.doi.org/10.1093/infdis/jis544

Luciani F; Bull RA; Lloyd AR; Bull , 2012, 'Next generation deep sequencing and vaccine design: Today and tomorrow', Trends in Biotechnology, 30, pp. 443 - 452, http://dx.doi.org/10.1016/j.tibtech.2012.05.005

Ahmadzai H; Cameron B; Chui JJ; Lloyd A; Wakefield D; Thomas PS, 2012, 'Peripheral blood responses to specific antigens and CD28 in sarcoidosis', Respir Med, 106, pp. 701 - 709, http://dx.doi.org/10.1016/j.rmed.2012.01.012

Back to profile page